IL-20 and its receptors are upregulated in the synovium of RA patients [46–50] and IL-19, IL-20 and IL-22 are able to increase the proliferation of synovial cells and induce IL-6, IL-8 and CCL2 in these cells [48, 50]. The gene discussed is CCL2; the disease is rheumatoid arthritis.